Caplin Point Lab's CRO arm completes USFDA audit with 'nil' observations
In a regulatory filing, Caplin Point Laboratories said Amaris Clinicals located at Chennai, has completed a virtual audit from United States Food and Drug Administration (USFDA) with ''nil'' observations.
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
CAPLIN POINT'S CRO AMARIS CLINICAL COMPLETES USFDA AUDIT WITH NIL OBSERVATIONS Caplin Point Laboratories Ltd - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015 CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
CAPLIN STERILES GETS USFDA APPROVAL FOR LABETALOL HYDROCHLORIDE INJECTION USP CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Disclosure under Regulations 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Caplin Point Laboratories Ltd - 524742 - Reg. 34 (1) Annual Report
Annual Report for the Financial Year ended March 31, 2021 Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 CAPLIN POINT LABORATORIES LTD. - 524742 - Intimation Of Book Closure And Record Date Pursuant To Regulation 42 Of The Securities And Exchanee Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)
Intimation of Book Closure and Record Date pursuant to Regulation 42 of the Securities and Exchanee Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Disclosure under Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015